Eastern Canada Cutaneous Research

Halifax, Nova Scotia B5H 1Z4

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2) — Completed
• Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3 — Completed